nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—TOP2A—malignant glioma	0.832	1	CbGaD
Idarubicin—Radiation injury—Temozolomide—malignant glioma	0.0166	0.144	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Carmustine—malignant glioma	0.011	0.095	CcSEcCtD
Idarubicin—Myelodysplastic syndrome—Temozolomide—malignant glioma	0.00869	0.0751	CcSEcCtD
Idarubicin—Myelosuppression—Carmustine—malignant glioma	0.00385	0.0332	CcSEcCtD
Idarubicin—Myelosuppression—Temozolomide—malignant glioma	0.00372	0.0321	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Carmustine—malignant glioma	0.00303	0.0262	CcSEcCtD
Idarubicin—Febrile neutropenia—Carmustine—malignant glioma	0.003	0.0259	CcSEcCtD
Idarubicin—Febrile neutropenia—Temozolomide—malignant glioma	0.0029	0.025	CcSEcCtD
Idarubicin—Valrubicin—TOP2A—malignant glioma	0.00282	0.277	CrCbGaD
Idarubicin—Embolism—Temozolomide—malignant glioma	0.00272	0.0235	CcSEcCtD
Idarubicin—Burning sensation—Carmustine—malignant glioma	0.0026	0.0224	CcSEcCtD
Idarubicin—Necrosis—Carmustine—malignant glioma	0.0023	0.0199	CcSEcCtD
Idarubicin—Daunorubicin—POR—malignant glioma	0.00216	0.213	CrCbGaD
Idarubicin—Extravasation—Carmustine—malignant glioma	0.00207	0.0179	CcSEcCtD
Idarubicin—Doxorubicin—POR—malignant glioma	0.00176	0.173	CrCbGaD
Idarubicin—Neoplasm—Carmustine—malignant glioma	0.00163	0.0141	CcSEcCtD
Idarubicin—Neoplasm—Temozolomide—malignant glioma	0.00158	0.0136	CcSEcCtD
Idarubicin—Sepsis—Carmustine—malignant glioma	0.00157	0.0135	CcSEcCtD
Idarubicin—Phlebitis—Carmustine—malignant glioma	0.00152	0.0131	CcSEcCtD
Idarubicin—Thrombophlebitis—Carmustine—malignant glioma	0.00151	0.0131	CcSEcCtD
Idarubicin—Thrombophlebitis—Temozolomide—malignant glioma	0.00146	0.0126	CcSEcCtD
Idarubicin—Hot flush—Temozolomide—malignant glioma	0.00135	0.0117	CcSEcCtD
Idarubicin—Menopausal symptoms—Temozolomide—malignant glioma	0.00134	0.0116	CcSEcCtD
Idarubicin—Epirubicin—TOP2A—malignant glioma	0.00123	0.121	CrCbGaD
Idarubicin—Dehydration—Temozolomide—malignant glioma	0.00118	0.0102	CcSEcCtD
Idarubicin—Pancytopenia—Carmustine—malignant glioma	0.00108	0.00929	CcSEcCtD
Idarubicin—Neutropenia—Carmustine—malignant glioma	0.00106	0.00914	CcSEcCtD
Idarubicin—Pancytopenia—Temozolomide—malignant glioma	0.00104	0.00897	CcSEcCtD
Idarubicin—Neutropenia—Temozolomide—malignant glioma	0.00102	0.00884	CcSEcCtD
Idarubicin—Stomatitis—Carmustine—malignant glioma	0.000984	0.0085	CcSEcCtD
Idarubicin—Stomatitis—Temozolomide—malignant glioma	0.000951	0.00821	CcSEcCtD
Idarubicin—Haemoglobin—Carmustine—malignant glioma	0.000911	0.00787	CcSEcCtD
Idarubicin—Haemorrhage—Carmustine—malignant glioma	0.000906	0.00783	CcSEcCtD
Idarubicin—Haemoglobin—Temozolomide—malignant glioma	0.00088	0.0076	CcSEcCtD
Idarubicin—Haemorrhage—Temozolomide—malignant glioma	0.000876	0.00756	CcSEcCtD
Idarubicin—Daunorubicin—TOP2A—malignant glioma	0.000868	0.0854	CrCbGaD
Idarubicin—Urinary tract disorder—Temozolomide—malignant glioma	0.000865	0.00747	CcSEcCtD
Idarubicin—Urethral disorder—Temozolomide—malignant glioma	0.000858	0.00741	CcSEcCtD
Idarubicin—Flushing—Carmustine—malignant glioma	0.000841	0.00726	CcSEcCtD
Idarubicin—Flushing—Temozolomide—malignant glioma	0.000813	0.00702	CcSEcCtD
Idarubicin—Arrhythmia—Carmustine—malignant glioma	0.00081	0.00699	CcSEcCtD
Idarubicin—Alopecia—Carmustine—malignant glioma	0.000801	0.00692	CcSEcCtD
Idarubicin—Angiopathy—Temozolomide—malignant glioma	0.000795	0.00686	CcSEcCtD
Idarubicin—Immune system disorder—Temozolomide—malignant glioma	0.000791	0.00683	CcSEcCtD
Idarubicin—Malnutrition—Carmustine—malignant glioma	0.000789	0.00681	CcSEcCtD
Idarubicin—Chills—Temozolomide—malignant glioma	0.000786	0.00679	CcSEcCtD
Idarubicin—Alopecia—Temozolomide—malignant glioma	0.000774	0.00668	CcSEcCtD
Idarubicin—Malnutrition—Temozolomide—malignant glioma	0.000762	0.00658	CcSEcCtD
Idarubicin—Anaemia—Carmustine—malignant glioma	0.000729	0.0063	CcSEcCtD
Idarubicin—Leukopenia—Carmustine—malignant glioma	0.000706	0.0061	CcSEcCtD
Idarubicin—Doxorubicin—TOP2A—malignant glioma	0.000705	0.0694	CrCbGaD
Idarubicin—Anaemia—Temozolomide—malignant glioma	0.000705	0.00609	CcSEcCtD
Idarubicin—Convulsion—Carmustine—malignant glioma	0.000683	0.0059	CcSEcCtD
Idarubicin—Leukopenia—Temozolomide—malignant glioma	0.000682	0.00589	CcSEcCtD
Idarubicin—Chest pain—Carmustine—malignant glioma	0.000672	0.0058	CcSEcCtD
Idarubicin—Convulsion—Temozolomide—malignant glioma	0.000661	0.0057	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000645	0.00557	CcSEcCtD
Idarubicin—Infection—Carmustine—malignant glioma	0.00064	0.00552	CcSEcCtD
Idarubicin—Thrombocytopenia—Carmustine—malignant glioma	0.00063	0.00544	CcSEcCtD
Idarubicin—Doxorubicin—CYP2B6—malignant glioma	0.000627	0.0617	CrCbGaD
Idarubicin—Anaphylactic shock—Temozolomide—malignant glioma	0.000622	0.00537	CcSEcCtD
Idarubicin—Infection—Temozolomide—malignant glioma	0.000618	0.00534	CcSEcCtD
Idarubicin—Anorexia—Carmustine—malignant glioma	0.000614	0.0053	CcSEcCtD
Idarubicin—Thrombocytopenia—Temozolomide—malignant glioma	0.000609	0.00526	CcSEcCtD
Idarubicin—Skin disorder—Temozolomide—malignant glioma	0.000604	0.00522	CcSEcCtD
Idarubicin—Anorexia—Temozolomide—malignant glioma	0.000593	0.00512	CcSEcCtD
Idarubicin—Decreased appetite—Carmustine—malignant glioma	0.00056	0.00483	CcSEcCtD
Idarubicin—Decreased appetite—Temozolomide—malignant glioma	0.000541	0.00467	CcSEcCtD
Idarubicin—Gastrointestinal pain—Carmustine—malignant glioma	0.000526	0.00455	CcSEcCtD
Idarubicin—Abdominal pain—Carmustine—malignant glioma	0.000509	0.0044	CcSEcCtD
Idarubicin—Body temperature increased—Carmustine—malignant glioma	0.000509	0.0044	CcSEcCtD
Idarubicin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000509	0.00439	CcSEcCtD
Idarubicin—Urticaria—Temozolomide—malignant glioma	0.000494	0.00427	CcSEcCtD
Idarubicin—Abdominal pain—Temozolomide—malignant glioma	0.000492	0.00425	CcSEcCtD
Idarubicin—Body temperature increased—Temozolomide—malignant glioma	0.000492	0.00425	CcSEcCtD
Idarubicin—Hypersensitivity—Carmustine—malignant glioma	0.000474	0.0041	CcSEcCtD
Idarubicin—Hypersensitivity—Temozolomide—malignant glioma	0.000458	0.00396	CcSEcCtD
Idarubicin—Diarrhoea—Carmustine—malignant glioma	0.000441	0.0038	CcSEcCtD
Idarubicin—Diarrhoea—Temozolomide—malignant glioma	0.000426	0.00368	CcSEcCtD
Idarubicin—Vomiting—Carmustine—malignant glioma	0.000409	0.00354	CcSEcCtD
Idarubicin—Rash—Carmustine—malignant glioma	0.000406	0.00351	CcSEcCtD
Idarubicin—Dermatitis—Carmustine—malignant glioma	0.000406	0.0035	CcSEcCtD
Idarubicin—Headache—Carmustine—malignant glioma	0.000403	0.00348	CcSEcCtD
Idarubicin—Vomiting—Temozolomide—malignant glioma	0.000396	0.00342	CcSEcCtD
Idarubicin—Rash—Temozolomide—malignant glioma	0.000392	0.00339	CcSEcCtD
Idarubicin—Dermatitis—Temozolomide—malignant glioma	0.000392	0.00339	CcSEcCtD
Idarubicin—Headache—Temozolomide—malignant glioma	0.00039	0.00337	CcSEcCtD
Idarubicin—Nausea—Carmustine—malignant glioma	0.000382	0.0033	CcSEcCtD
Idarubicin—Nausea—Temozolomide—malignant glioma	0.00037	0.00319	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000284	0.00671	CbGpPWpGaD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—malignant glioma	0.000283	0.00668	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TUBG2—malignant glioma	0.000283	0.00668	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000276	0.00653	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—MYC—malignant glioma	0.000276	0.00651	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000274	0.00647	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000273	0.00644	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00027	0.00639	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—EGFR—malignant glioma	0.00027	0.00637	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000253	0.00598	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—PML—malignant glioma	0.000243	0.00574	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00024	0.00566	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000237	0.00561	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000236	0.00558	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000234	0.00554	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—TP53—malignant glioma	0.000226	0.00535	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000224	0.00529	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000222	0.00525	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.000219	0.00518	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000208	0.00492	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000194	0.00459	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000193	0.00455	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00018	0.00426	CbGpPWpGaD
Idarubicin—ABCC1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00018	0.00424	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—NTRK1—malignant glioma	0.000173	0.00409	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000173	0.00408	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000172	0.00407	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000168	0.00396	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000166	0.00392	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00016	0.00378	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—NCOR1—malignant glioma	0.000151	0.00357	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000151	0.00356	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000147	0.00348	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000146	0.00346	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000146	0.00345	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000145	0.00343	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000144	0.0034	CbGpPWpGaD
Idarubicin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000138	0.00326	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000135	0.00318	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—RTEL1—malignant glioma	0.00013	0.00308	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PLK1—malignant glioma	0.00013	0.00307	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—HIST1H3B—malignant glioma	0.000129	0.00304	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000128	0.00302	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.000125	0.00296	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000124	0.00294	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000121	0.00285	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000121	0.00285	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000119	0.00281	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000118	0.00279	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000117	0.00277	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000117	0.00276	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000116	0.00275	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000116	0.00273	CbGpPWpGaD
Idarubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—malignant glioma	0.000115	0.00272	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000111	0.00262	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—PPARG—malignant glioma	0.000108	0.00256	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000107	0.00253	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000103	0.00244	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000102	0.00242	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000102	0.0024	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000101	0.00238	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—H3F3A—malignant glioma	9.93e-05	0.00235	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	9.91e-05	0.00234	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	9.84e-05	0.00233	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—YWHAE—malignant glioma	9.57e-05	0.00226	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	9.35e-05	0.00221	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.32e-05	0.0022	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	9.21e-05	0.00218	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	9.18e-05	0.00217	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	9.08e-05	0.00214	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.02e-05	0.00213	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	8.88e-05	0.0021	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	8.49e-05	0.00201	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTT1—malignant glioma	8.34e-05	0.00197	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTT1—malignant glioma	8.27e-05	0.00195	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	8.24e-05	0.00195	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	8.04e-05	0.0019	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	7.98e-05	0.00189	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—PTGS1—malignant glioma	7.82e-05	0.00185	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—PTGS1—malignant glioma	7.75e-05	0.00183	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	7.74e-05	0.00183	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—COX8A—malignant glioma	7.49e-05	0.00177	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	7.43e-05	0.00176	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—BRCA2—malignant glioma	7.25e-05	0.00171	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2B—malignant glioma	7.19e-05	0.0017	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BCAN—malignant glioma	7.15e-05	0.00169	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	6.99e-05	0.00165	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	6.94e-05	0.00164	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.7e-05	0.00158	CbGpPWpGaD
Idarubicin—ABCC1—Disease—DTX1—malignant glioma	6.47e-05	0.00153	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.44e-05	0.00152	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ASMT—malignant glioma	6.37e-05	0.0015	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.37e-05	0.0015	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6.29e-05	0.00149	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.23e-05	0.00147	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—BIRC5—malignant glioma	6.2e-05	0.00147	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TERT—malignant glioma	6.01e-05	0.00142	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	5.99e-05	0.00142	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—BCAN—malignant glioma	5.99e-05	0.00141	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	5.95e-05	0.0014	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—RTEL1—malignant glioma	5.85e-05	0.00138	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.85e-05	0.00138	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—RTEL1—malignant glioma	5.8e-05	0.00137	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTP1—malignant glioma	5.78e-05	0.00137	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTP1—malignant glioma	5.73e-05	0.00135	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	5.7e-05	0.00135	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	5.65e-05	0.00134	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.57e-05	0.00131	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.46e-05	0.00129	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.28e-05	0.00125	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HEY2—malignant glioma	5.07e-05	0.0012	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—malignant glioma	5.07e-05	0.0012	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IDH1—malignant glioma	4.96e-05	0.00117	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—IDH2—malignant glioma	4.83e-05	0.00114	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HEY1—malignant glioma	4.7e-05	0.00111	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	4.6e-05	0.00109	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIST1H3B—malignant glioma	4.57e-05	0.00108	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.55e-05	0.00108	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP2B6—malignant glioma	4.54e-05	0.00107	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.46e-05	0.00105	CbGpPWpGaD
Idarubicin—ABCC1—Disease—JAG2—malignant glioma	4.17e-05	0.000984	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—IDH1—malignant glioma	4.15e-05	0.000981	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.14e-05	0.000979	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2A—malignant glioma	4.11e-05	0.000971	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SPHK1—malignant glioma	4.02e-05	0.000949	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.01e-05	0.000947	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MDM2—malignant glioma	3.99e-05	0.000942	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP2C18—malignant glioma	3.94e-05	0.00093	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.71e-05	0.000877	CbGpPWpGaD
Idarubicin—ABCC1—Disease—H3F3A—malignant glioma	3.53e-05	0.000833	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.38e-05	0.000798	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—COX8A—malignant glioma	3.36e-05	0.000793	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—COX8A—malignant glioma	3.33e-05	0.000786	CbGpPWpGaD
Idarubicin—ABCC1—Disease—JAG1—malignant glioma	3.32e-05	0.000785	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.26e-05	0.000771	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FBXW7—malignant glioma	3.26e-05	0.000769	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTT1—malignant glioma	3.18e-05	0.000752	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	3.12e-05	0.000736	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS1—malignant glioma	2.98e-05	0.000704	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.98e-05	0.000703	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.97e-05	0.000702	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ASMT—malignant glioma	2.86e-05	0.000675	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ASMT—malignant glioma	2.83e-05	0.000669	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—malignant glioma	2.79e-05	0.000658	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—BCHE—malignant glioma	2.77e-05	0.000655	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.77e-05	0.000654	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC5A5—malignant glioma	2.74e-05	0.000647	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BCAN—malignant glioma	2.68e-05	0.000634	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BCAN—malignant glioma	2.66e-05	0.000629	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.59e-05	0.000612	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.57e-05	0.000606	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN2B—malignant glioma	2.55e-05	0.000603	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.52e-05	0.000596	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HES1—malignant glioma	2.43e-05	0.000575	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NCOR1—malignant glioma	2.42e-05	0.000572	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PDGFRA—malignant glioma	2.32e-05	0.000548	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—malignant glioma	2.29e-05	0.00054	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.24e-05	0.000529	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTP1—malignant glioma	2.21e-05	0.000521	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—IDH2—malignant glioma	2.16e-05	0.000511	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CAT—malignant glioma	2.15e-05	0.000507	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—IDH2—malignant glioma	2.15e-05	0.000507	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HLA-A—malignant glioma	2.13e-05	0.000504	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TERT—malignant glioma	2.13e-05	0.000504	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PDGFB—malignant glioma	2.08e-05	0.000492	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGFR1—malignant glioma	2.07e-05	0.000489	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIF1A—malignant glioma	2.04e-05	0.000482	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.03e-05	0.000481	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NCOR1—malignant glioma	2.03e-05	0.000479	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.02e-05	0.000478	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.02e-05	0.000476	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CAV1—malignant glioma	1.97e-05	0.000466	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—IDH1—malignant glioma	1.86e-05	0.00044	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BAD—malignant glioma	1.86e-05	0.000438	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—IDH1—malignant glioma	1.84e-05	0.000436	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOTCH1—malignant glioma	1.84e-05	0.000434	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SPHK1—malignant glioma	1.8e-05	0.000425	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD80—malignant glioma	1.8e-05	0.000425	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APC—malignant glioma	1.8e-05	0.000425	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SPHK1—malignant glioma	1.79e-05	0.000422	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGF—malignant glioma	1.78e-05	0.00042	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTPN11—malignant glioma	1.77e-05	0.000417	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.76e-05	0.000417	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.75e-05	0.000413	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BRAF—malignant glioma	1.69e-05	0.000399	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CAV1—malignant glioma	1.65e-05	0.00039	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.65e-05	0.00039	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT2—malignant glioma	1.64e-05	0.000388	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CD—malignant glioma	1.58e-05	0.000373	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.58e-05	0.000373	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF2—malignant glioma	1.51e-05	0.000357	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CG—malignant glioma	1.51e-05	0.000356	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.5e-05	0.000355	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPARG—malignant glioma	1.45e-05	0.000343	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.45e-05	0.000342	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTT1—malignant glioma	1.43e-05	0.000337	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MDM2—malignant glioma	1.42e-05	0.000334	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTT1—malignant glioma	1.41e-05	0.000334	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RAF1—malignant glioma	1.41e-05	0.000333	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB2—malignant glioma	1.4e-05	0.00033	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CB—malignant glioma	1.38e-05	0.000325	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—malignant glioma	1.36e-05	0.000322	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS1—malignant glioma	1.34e-05	0.000316	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS1—malignant glioma	1.33e-05	0.000313	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CD—malignant glioma	1.32e-05	0.000313	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.32e-05	0.000312	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BCHE—malignant glioma	1.24e-05	0.000294	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BCHE—malignant glioma	1.23e-05	0.000291	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.23e-05	0.00029	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.22e-05	0.000288	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTEN—malignant glioma	1.19e-05	0.000281	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CB—malignant glioma	1.15e-05	0.000272	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.15e-05	0.000272	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—malignant glioma	1.14e-05	0.00027	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.14e-05	0.000269	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT3—malignant glioma	1.06e-05	0.000251	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTEN—malignant glioma	9.97e-06	0.000235	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.95e-06	0.000235	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—malignant glioma	9.89e-06	0.000234	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTP1—malignant glioma	9.89e-06	0.000234	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTP1—malignant glioma	9.8e-06	0.000232	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—malignant glioma	9.67e-06	0.000229	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CAT—malignant glioma	9.62e-06	0.000227	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CAT—malignant glioma	9.54e-06	0.000225	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KRAS—malignant glioma	9.14e-06	0.000216	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOR1—malignant glioma	9.09e-06	0.000215	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOR1—malignant glioma	9.01e-06	0.000213	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—malignant glioma	8.4e-06	0.000198	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CAV1—malignant glioma	7.41e-06	0.000175	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CAV1—malignant glioma	7.34e-06	0.000173	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—malignant glioma	7.03e-06	0.000166	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.02e-06	0.000166	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—malignant glioma	6.86e-06	0.000162	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.75e-06	0.000159	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.69e-06	0.000158	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPARG—malignant glioma	6.51e-06	0.000154	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPARG—malignant glioma	6.46e-06	0.000153	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.93e-06	0.00014	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.88e-06	0.000139	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—malignant glioma	5.74e-06	0.000136	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.17e-06	0.000122	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.13e-06	0.000121	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—malignant glioma	5.12e-06	0.000121	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—malignant glioma	5.08e-06	0.00012	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTEN—malignant glioma	4.47e-06	0.000106	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTEN—malignant glioma	4.43e-06	0.000105	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.15e-06	7.45e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.13e-06	7.38e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—malignant glioma	2.58e-06	6.08e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—malignant glioma	2.55e-06	6.03e-05	CbGpPWpGaD
